RIA
SBIO icon

Rhodes Investment Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Rhodes Investment Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$266K Buy
+4,555
New +$297K 0.19% 103

Other funds holding SBIO

FFAS
FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Rhodes Investment Advisors's SBIO Position: Q3 2026 in Review

Rhodes Investment Advisors opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q3 2026: 4,555 shares worth $266K. The stake represents 0.19% of the portfolio and ranks #103 among its holdings.

3 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.

  • Rhodes Investment Advisors held 4,555 shares of ALPS Medical Breakthroughs ETF worth $266K as of Q3 2026.
  • ALPS Medical Breakthroughs ETF was a new Rhodes Investment Advisors position in Q3 2026.
  • ALPS Medical Breakthroughs ETF made up 0.19% of Rhodes Investment Advisors's portfolio in Q3 2026, its #103 holding.
  • 3 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.

Based on Rhodes Investment Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.